A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Kidney Problems
Status:
Not yet recruiting
Trial end date:
2023-08-16
Target enrollment:
Participant gender:
Summary
This study is open to adults aged 18 years and older. People without kidney problems and
people who have moderate or severe kidney problems can join the study.
The purpose of this study is to find out how a medicine called BI 1015550 is taken up in the
blood of people with and without kidney problems. Kidney problems may change how a medicine
is taken up in the blood. All participants take a single tablet of BI 1015550.
Participants are in the study for about 2 weeks. During this time, they visit the study site
6 times. On the second visit, participants stay overnight at the study site for 4 nights. At
the visits, doctors take blood samples to measure the levels of BI 1015550 in participants'
blood. Then they compare the results between the groups of participants with and without
kidney problems. The doctors also check participants' health and take note of any unwanted
effects.